Peptides vs HGH: HGH (somatropin) replaces growth hormone directly and is FDA-approved for diagnosed growth hormone deficiency and a few other conditions.[1] Growth hormone peptides such as sermorelin, CJC-1295, ipamorelin and MK-677 instead prompt the pituitary to release more of your own.[15] In healthy older adults, HGH added about 2 kg of lean mass but caused frequent swelling and joint pain, and reviewers concluded it cannot be recommended for anti-aging.[4] Only one growth hormone peptide, tesamorelin, is currently FDA-approved, and only for HIV-associated belly fat.[9]
See the HGH profile, the growth hormone peptides hub and all growth hormone compounds.
Peptides vs HGH at a glance
| HGH (somatropin) | Growth hormone peptides | |
|---|---|---|
| How it works | Replaces growth hormone[1] | Signals the pituitary to release its own[15] |
| Needs a working pituitary | No | Yes |
| FDA-approved uses | Growth hormone deficiency in children and adults, plus several rare conditions[1] | Tesamorelin only, for HIV-associated abdominal fat[9] |
| Strongest evidence | Meta-analysis of 37 blinded trials in deficient adults[3] | Tesamorelin phase 3 trials;[10] others mostly short hormone studies[15] |
| Anti-aging use | Illegal to distribute in the U.S.[7] | No GHRH product approved for anti-aging[14] |
| Common side effects | Swelling, joint pain, tingling, carpal tunnel[1] | Vary by compound: flushing, hunger, blood sugar rises[11][15] |
| Banned in sport | Yes[18] | Yes[18] |
How each approach works
The pituitary gland releases growth hormone in pulses, mostly at night. Growth hormone raises IGF-1, which drives many of its effects.
- HGH is the 191-amino-acid hormone itself, made by recombinant DNA technology. In deficient adults it reduces fat and increases lean mass.[1]
- GHRH analogs (sermorelin, tesamorelin, CJC-1295) copy the brain’s growth hormone-releasing hormone.
- Ghrelin mimics (ipamorelin, GHRP-6, hexarelin, and the oral non-peptide MK-677) act on the ghrelin receptor.
The usual argument for peptides is that the body’s feedback system stays in charge, which may limit how high growth hormone goes. That is plausible, but it has not been shown in a head-to-head safety trial against HGH.
Evidence quality
HGH is backed by large, controlled trials for its approved uses. In adults with growth hormone deficiency, a meta-analysis of 37 blinded trials found it raised lean mass by 2.7 kg, cut fat by 3.1 kg and lowered LDL cholesterol, but raised fasting glucose and insulin.[3] The Endocrine Society says treatment helps body composition, exercise capacity, bone and quality of life, and that diagnosis usually needs a stimulation test.[2]
For healthy people, the picture is weaker:
- Older adults: across 18 study groups, fat fell 2.1 kg and lean mass rose 2.1 kg, with more swelling, joint pain and carpal tunnel syndrome.[4] In a JAMA trial of 131 people aged 65 to 88, strength barely changed.[5]
- Athletes: lean mass rose but strength did not seem to improve.[6] In 96 recreational athletes, sprint capacity rose 3.9%, but strength, power and endurance did not change.[19]
Peptides are mostly earlier-stage. Tesamorelin cut deep belly fat by 15.2% versus a 5.0% rise on placebo over 26 weeks in 412 people with HIV.[10] MK-677 added 1.1 kg of lean mass over two years in older adults but raised blood sugar and did not improve strength.[11] CJC-1295 raised growth hormone and IGF-1 for days in healthy adults, with no outcome trials.[12] A 2026 review placed most growth hormone peptides in early or minimal evidence tiers.[15]
Side effects and safety
HGH (Genotropin adult trials, first 6 months):[1]
| Side effect | HGH | Placebo |
|---|---|---|
| Peripheral swelling | 17.5% | 5.1% |
| Joint pain | 17.3% | 4.2% |
| Tingling or numbness | 9.6% | 1.9% |
The label also warns about blood sugar changes, raised pressure in the skull and growth of existing tumors.[1]
Peptides: risks differ by compound. MK-677 raised fasting glucose and caused swelling in 44% of users.[11] A 2026 review listed raised prolactin or cortisol, appetite changes, blood sugar problems, fluid retention and injection-site reactions across the class.[15] Unapproved peptides sold online also carry uncertain purity and dose.[15]
Doses: label vs research
HGH doses are set by a doctor from the label and adjusted by response and IGF-1 levels. For adult growth hormone deficiency, the Genotropin label starts at about 0.2 mg a day (range 0.15 to 0.30) and raises it gradually every 1 to 2 months.[1] Doses used for anti-aging or bodybuilding are not on any label; the 2010 athlete trial used 2 mg a day.[19]
Peptide doses come only from trials or from sellers:
- Tesamorelin: 2 mg under the skin daily in its HIV trial.[10]
- MK-677: 25 mg by mouth daily in the two-year trial.[11]
- CJC-1295 with DAC: single or repeated injections days apart in healthy-adult studies.[12]
A 2026 review warned that peptide protocols promoted online are not validated.[15] A clinician should set any dose.
Legal status, cost and access
- HGH: prescription only. Under 21 U.S.C. 333(e), distributing it for anything other than an FDA-authorized treatment ordered by a doctor carries up to 5 years in prison.[7][8]
- Tesamorelin: FDA-approved for HIV-associated abdominal fat.[9]
- Sermorelin: its brand was discontinued in 2008, but FDA found this was not for safety reasons, so it can be compounded.[13]
- Ipamorelin, MK-677 and CJC-1295: FDA advisers voted against allowing them in compounding in 2024.[16][17]
Insurance coverage of HGH depends on your plan and a documented diagnosis, so check with your insurer. For the broader legal picture, see FDA-approved peptides. This is general information, not legal advice.
Questions to discuss with a clinician
- Have I been tested for growth hormone deficiency? That diagnosis opens approved treatment.[2]
- Do I have diabetes, cancer history or carpal tunnel? These matter for HGH and several peptides.[1][11]
- Which peptide, if any, has human data for my goal? Compare tesamorelin vs sermorelin and CJC-1295 vs sermorelin.
The verdict
HGH is the proven treatment for growth hormone deficiency, with large trials and clear labeling, but for healthy people it adds lean mass without strength and brings real side effects.[3][4] Growth hormone peptides are less proven: tesamorelin is approved for one narrow use, and the rest have mostly short-term hormone data.[9][15] The idea that peptides are a “safer HGH” has not been tested directly. See also MK-677 vs CJC-1295 ipamorelin.
